This year, the event will focus on technologies related to integrated 3D, human-derived systems—from organoids to organ-on-a-chip (brain/heart/intestine; disease models; cancer; drug testing). The specific technological pillars and methods will be shaped by the speakers. Expect deep dives into precision microfabrication for compartmentalized tissues and barrier models; advanced bioinks and biofabrication for reproducible constructs; microfluidic platforms with valves, perfusion, and on-chip environments; and smart materials that enable membranes, scaffolds, and soft actuation. We will highlight high-throughput automation for dispensing, spotting, and sample handling; integrated sensing and micro/nanoelectronics for electrical, optical, and chemical measurements; and AI-powered imaging pipelines that connect capture, analysis, and closed-loop experiments. Together, these building blocks flow into scalable screening platforms that transition seamlessly from proof-of-concept to robust, real-world application.